This explains why XP-C and XP-E patients (but XP-E patients are very rare) are more likely to have early onset of skin cancers than XP patients who are TCR and GGR deficient (XP-A, XP-B, XP-D, and XP-G) [3,35]. Here, ERCC3 is linked to skin cancer.